• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院如何管理蛋白药物?采用人为因素和系统工程学方法比较两家医院并提出最佳实践建议。

How are we handling protein drugs in hospitals? A human factors and systems engineering approach to compare two hospitals and suggest a best practice.

机构信息

Department of Women's and Children's Health, Uppsala University, Akademiska sjukhuset, Entrance 95/96, Uppsala 751 85, Sweden.

Faculty of Pharmacy and Food Science, University of Barcelona, c/Joan XXIII, 27-31, Barcelona 08028, Spain.

出版信息

Int J Qual Health Care. 2024 Mar 18;36(1). doi: 10.1093/intqhc/mzae020.

DOI:10.1093/intqhc/mzae020
PMID:38462489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11002458/
Abstract

Biopharmaceuticals are complex biological molecules that require careful storage and handling to ensure medication integrity. In this study, a work system analysis of real-world protein drug (PD) handling was performed with the following goals: identify main barriers and facilitators for successful adherence to accepted recommendations in PD handling, analyse differences in two organizations, and define a Best Current Practice in the real-life handling of PDs based on the results of the work system analysis. Observational study was held in two university hospitals in Spain and Sweden. Based on the Systems Engineering Initiative for Patient Safety (SEIPS) model, the tools chosen were: the PETT scan, in order to indicate the presence of barriers or facilitators for the PETT components (People, Environment, Tools, Tasks); the Tasks and tools matrices to construct a checklist to record direct observations during the real-life handling of biopharmaceuticals, and the Journey map to depict the work process. Observations were performed between March and November 2022. Each episode of direct observation included a single protein drug in some point of the supply chain and considered all the elements in the work system. Based on the results of the work system analysis and the literature review, the authors propose a list of items which could be assumed as Best Current Practice for PDs handling in hospitals. There were a total of 34 observations involving 19 PDs. Regarding People involved in the work process, there was a diversity of professionals with different previous training and knowledge, leading to an information gap. With respect to Environment, some structural and organizational differences between hospitals lead to risks related to the time exposure of PDs to room temperature and mechanical stress. Some differences also existed in the Tools and Tasks involved in the process, being especially relevant to the lack of compatibility information of PDs with new technologies, such as pneumatic tube system, robotic reconstitution, or closed-system transfer devices. Finally, 15 suggestions for best current practice are proposed. Main barriers found for compliance with accepted recommendations were related to the information gap detected in professionals involved in the handling of protein drugs, unmonitored temperature, and the lack of compatibility information of protein drugs with some new technologies. By applying a Human Factors and Systems Engineering Approach, the comparison of two European hospitals has led to a suggested list of Best Current Practices in the handling of protein drugs in a hospital.

摘要

生物制药是复杂的生物分子,需要小心储存和处理以确保药物的完整性。在这项研究中,对现实世界中蛋白质药物 (PD) 处理进行了工作系统分析,目的是:确定成功遵守 PD 处理接受建议的主要障碍和促进因素,分析两个组织之间的差异,并根据工作系统分析的结果定义 PD 实际处理中的最佳当前实践。观察性研究在西班牙和瑞典的两所大学医院进行。基于患者安全系统工程倡议 (SEIPS) 模型,选择的工具是:PETT 扫描,以指示 PETT 组件(人员、环境、工具、任务)存在的障碍或促进因素;任务和工具矩阵,以构建记录生物制药实际处理过程中直接观察结果的检查表,并绘制工作流程的旅程图。观察于 2022 年 3 月至 11 月进行。每次直接观察的事件都包括供应链中的单个蛋白质药物,并考虑了工作系统中的所有元素。根据工作系统分析和文献综述的结果,作者提出了一份清单,其中包含一些可以作为医院 PD 处理最佳当前实践的项目。共有 34 次观察,涉及 19 种 PD。在参与工作过程的人员方面,存在不同专业和不同先前培训和知识的多样性,导致信息差距。在环境方面,医院之间的一些结构和组织差异导致 PD 暴露在室温下和机械压力下的时间风险。处理过程中涉及的工具和任务也存在一些差异,特别是 PD 与新技术(如气动输送系统、机器人重组或密闭式转移装置)缺乏兼容性信息的问题尤为重要。最后,提出了 15 条最佳实践建议。发现与遵守接受的建议相关的主要障碍与处理蛋白质药物的专业人员中的信息差距、未监测的温度以及蛋白质药物与一些新技术缺乏兼容性信息有关。通过应用人为因素和系统工程方法,对两家欧洲医院的比较导致了在医院处理蛋白质药物的最佳实践建议清单。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc55/11002458/eef504cb0dc0/mzae020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc55/11002458/343dfc955b20/mzae020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc55/11002458/eef504cb0dc0/mzae020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc55/11002458/343dfc955b20/mzae020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc55/11002458/eef504cb0dc0/mzae020f2.jpg

相似文献

1
How are we handling protein drugs in hospitals? A human factors and systems engineering approach to compare two hospitals and suggest a best practice.医院如何管理蛋白药物?采用人为因素和系统工程学方法比较两家医院并提出最佳实践建议。
Int J Qual Health Care. 2024 Mar 18;36(1). doi: 10.1093/intqhc/mzae020.
2
Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.封闭系统药物转移装置加危险药物安全操作与仅进行安全操作相比,对减少医护人员接触输注性危险药物的影响
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD012860. doi: 10.1002/14651858.CD012860.pub2.
3
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
6
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
9
Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).与火星样本返回(MSR)相关的对灭菌敏感的科学研究的规划意义。
Astrobiology. 2022 Jun;22(S1):S112-S164. doi: 10.1089/AST.2021.0113. Epub 2022 May 19.
10
Examination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures.瑞典某大学医院蛋白质药物供应链检查:关注风险处理与缓解措施
J Pharm Sci. 2023 Nov;112(11):2799-2810. doi: 10.1016/j.xphs.2023.05.003. Epub 2023 May 7.

本文引用的文献

1
Examination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures.瑞典某大学医院蛋白质药物供应链检查:关注风险处理与缓解措施
J Pharm Sci. 2023 Nov;112(11):2799-2810. doi: 10.1016/j.xphs.2023.05.003. Epub 2023 May 7.
2
New therapeutic modalities in drug discovery and development: Insights & opportunities.药物发现与开发中的新治疗模式:见解与机遇。
ADMET DMPK. 2021 Dec 15;9(4):227-230. doi: 10.5599/admet.1209. eCollection 2021.
3
Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple Methods.
通过医院气动管道系统运输含蛋白质制剂的静脉输液袋的影响:多种方法进行颗粒表征
J Pharm Sci. 2022 Apr;111(4):1024-1039. doi: 10.1016/j.xphs.2022.01.016. Epub 2022 Jan 31.
4
Stress Factors in Primary Packaging, Transportation and Handling of Protein Drug Products and Their Impact on Product Quality.蛋白质药物产品的初级包装、运输和处理中的应激因素及其对产品质量的影响。
J Pharm Sci. 2022 Apr;111(4):887-902. doi: 10.1016/j.xphs.2022.01.011. Epub 2022 Jan 23.
5
A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development.药品研发过程中评估封闭系统药物转移装置的系统方法。
J Pharm Sci. 2022 May;111(5):1325-1334. doi: 10.1016/j.xphs.2021.12.020. Epub 2021 Dec 24.
6
SEIPS 101 and seven simple SEIPS tools.SEIPS 101和七个简单的SEIPS工具。
BMJ Qual Saf. 2021 Nov;30(11):901-910. doi: 10.1136/bmjqs-2020-012538. Epub 2021 May 26.
7
Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners.封闭式输液器在肿瘤生物制剂治疗中的应用:加拿大医护人员的调查。
J Oncol Pharm Pract. 2022 Jun;28(4):805-815. doi: 10.1177/10781552211010928. Epub 2021 May 18.
8
Thermolabile drug storage in an ambulatory setting.室温不稳定药物在门诊环境下的储存。
Sci Rep. 2021 Mar 16;11(1):5959. doi: 10.1038/s41598-021-85413-0.
9
Do not flick or drop off-label use plastic syringes in handling therapeutic proteins before administration.在给药前处理治疗性蛋白时,请勿弹拨或丢弃非标签使用的塑料注射器。
Int J Pharm. 2020 Sep 25;587:119704. doi: 10.1016/j.ijpharm.2020.119704. Epub 2020 Jul 31.
10
DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.从聚氯乙烯 IV 袋中浸出的 DEHP 纳米液滴促进 IVIG 聚集并激活人血清中的补体。
J Pharm Sci. 2020 Jan;109(1):429-442. doi: 10.1016/j.xphs.2019.06.015. Epub 2019 Jun 21.